The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADMA BIOLOGICS INC | COM | 000899104 | 32,593,305 | 9,104,275 | SH | SOLE | 9,104,275 | 0 | 0 | |||
ALIMERA SCIENCES INC | COM NEW | 016259202 | 12,349,427 | 3,983,686 | SH | SOLE | 3,983,686 | 0 | 0 | |||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 46,065,543 | 2,515,868 | SH | SOLE | 2,515,868 | 0 | 0 | |||
ASSERTIO HOLDINGS INC | COM NEW | 04546C205 | 2,435,064 | 951,197 | SH | SOLE | 951,197 | 0 | 0 | |||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 5,160,000 | 1,720,000 | SH | SOLE | 1,720,000 | 0 | 0 | |||
AYTU BIOPHARMA INC | COM | 054754858 | 1,275,396 | 472,369 | SH | SOLE | 472,369 | 0 | 0 | |||
DELCATH SYSTEMS INC | COM NEW | 24661P807 | 2,779,272 | 686,240 | SH | SOLE | 686,240 | 0 | 0 | |||
EVOLUS INC | COM | 30052C107 | 47,336,097 | 5,179,004 | SH | SOLE | 5,179,004 | 0 | 0 | |||
GALAPAGOS NV-SPON ADR | SPONS ADR | 36315X101 | 27,727,895 | 802,544 | SH | SOLE | 802,544 | 0 | 0 | |||
GAMIDA CELL LTD | SHS | M47364100 | 8,204,841 | 7,965,865 | SH | SOLE | 7,965,865 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 2,781,056 | 3,339,405 | SH | SOLE | 3,339,405 | 0 | 0 | |||
IO BIOTECH INC | COM | 449778109 | 2,785,184 | 1,975,308 | SH | SOLE | 1,975,308 | 0 | 0 | |||
ATYR PHARMA INC | COM NEW | 002120202 | 7,310,066 | 4,626,624 | SH | SOLE | 4,626,624 | 0 | 0 | |||
MAXCYTE INC | COM | 57777K106 | 11,736,317 | 3,761,640 | SH | SOLE | 3,761,640 | 0 | 0 | |||
QUIDELORTHO CORP | COM | 219798105 | 48,118,314 | 658,794 | SH | SOLE | 658,794 | 0 | 0 | |||
REZOLUTE INC | COM NEW | 76200L309 | 4,055,668 | 3,072,476 | SH | SOLE | 3,072,476 | 0 | 0 | |||
SCYNEXIS INC | COM NEW | 811292200 | 6,503,926 | 2,852,599 | SH | SOLE | 2,852,599 | 0 | 0 | |||
TELA BIO INC | COM | 872381108 | 3,935,352 | 491,919 | SH | SOLE | 491,919 | 0 | 0 | |||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 2,064,541 | 477,903 | SH | SOLE | 477,903 | 0 | 0 | |||
XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 11,002,592 | 5,915,372 | SH | SOLE | 5,915,372 | 0 | 0 | |||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 5,748,317 | 5,273,685 | SH | SOLE | 5,273,685 | 0 | 0 | |||
EXAGEN INC | COM | 30068X103 | 2,912,448 | 1,203,491 | SH | SOLE | 1,203,491 | 0 | 0 | |||
XOMA CORP | COM NEW | 98419J206 | 6,151,722 | 436,602 | SH | SOLE | 436,602 | 0 | 0 |